Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments

Abstract Traditional cancer treatments use nonspecific drugs and monoclonal antibodies to target tumor cells. Chimeric antigen receptor (CAR)-T cell therapy, however, leverages the immune system's T-cells to recognize and attack tumor cells. T-cells are isolated from patients and modified to target...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Gunjan Dagar, Ashna Gupta, Tariq Masoodi, Sabah Nisar, Maysaloun Merhi, Sheema Hashem, Ravi Chauhan, Manisha Dagar, Sameer Mirza, Puneet Bagga, Rakesh Kumar, Ammira S. Al-Shabeeb Akil, Muzafar A. Macha, Mohammad Haris, Shahab Uddin, Mayank Singh, Ajaz A. Bhat
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2023-07-01
Serie:	Journal of Translational Medicine
Soggetti:	CAR-T cell therapy Immunotherapy Tumor antigens Antigen escape Cytokine release syndrome Hematological malignancy
Accesso online:	https://doi.org/10.1186/s12967-023-04292-3
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!